San Francisco, CA, United States of America

Paul G Heyworth

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Schering Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul G Heyworth. Retrieved from https://idiyas.com/inventor/paul-g-heyworth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul G Heyworth

Introduction

Paul G Heyworth is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly through his work on antibodies. His innovative approach has led to the development of a patent that addresses critical health issues.

Latest Patents

Paul G Heyworth holds a patent for Anti-MDL-1 antibodies. This patent provides antibodies to human MDL-1, which have potential uses in the treatment of immune disorders, especially infectious diseases and sepsis. His work in this area highlights the importance of targeted therapies in modern medicine.

Career Highlights

Heyworth is associated with Schering Corporation, where he has been instrumental in advancing research and development in immunological treatments. His expertise and dedication have positioned him as a key figure in his field.

Collaborations

Throughout his career, Paul G Heyworth has collaborated with notable colleagues, including Joseph H Phillips and Michael Eric Bigler. These partnerships have fostered innovation and contributed to the success of various projects.

Conclusion

Paul G Heyworth's contributions to the field of immunology through his patent and collaborations underscore his role as a significant inventor. His work continues to impact the treatment of immune disorders, paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…